Medadvisor Ltd (MDR) — Capital Reinvestment Ratio

Latest as of December 2023: 0.07x

Medadvisor Ltd (MDR) has a Capital Reinvestment Ratio of 0.07x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$11.04 Million) in capital expenditures (AU$821.44K). See Medadvisor Ltd balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

AU$11.04 Million

AUD

Capital Expenditures

AU$821.44K

AUD

Data as of

Dec 2023

Most recent filing

Medadvisor Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Medadvisor Ltd's Capital Reinvestment Ratio across 1 annual periods. Check MDR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Medadvisor Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Medadvisor Ltd from 2024 to 2024. For live market cap and broader valuation context, see market cap of Medadvisor Ltd.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.35x	AU$5.19 Million	AU$1.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow